Professional & Business

  • International Medical Press

IVF cuts defy national guidelines

  • International Medical Press

Meningitis vaccination plan for Hampshire schoolchildren

  • International Medical Press

NHS budget cuts leave sexual health services at ‘breaking point’

  • International Medical Press

Wales to adopt new regulations for blood donation

  • International Medical Press

NICE: GPs urged to create national autism register

  • International Medical Press

£1.3bn recruitment plan for mental health

View more

New in Rheumatoid arthritis

  • Global Clinical Summaries from Semin Arthritis Rheum
  • 1 comment

Women with RA are likelier to develop COPD, regardless of smoking

But asthma risk is not increased.

  • Global Clinical Summaries from Arthritis Care Res
  • 1 comment

RA: watch out for signs of COPD

The disease may arguably be considered a complication of rheumatoid arthritis.

  • Global Clinical Summaries from Arthritis Res Ther
  • 1 comment

Antirheumatic therapy linked to improved cardiovascular function

Results of a small study.

Joint and Bone Disease: Monthly Essentials October 2017
  • Global Monthly Essentials
  • 1 comment

Joint and Bone Disease: Monthly Essentials October 2017

Infection risk with biologics in juvenile arthritis | Options for treatment-refractory RA.

  • Global Clinical Summaries from Rheumatol Int
  • 1 comment

RA: janus kinase inhibitor also protects against vascular damage

Results of a small study.

  • Global Clinical Summaries from Int J Epidemiol
  • 1 comment

Immune-related conditions increase GBS risk for women

A longitudinal cohort study among more than 1.1 million parous women.

New therapy approved for rheumatoid arthritis
  • UK Medical News
  • 1 comment

New therapy approved for rheumatoid arthritis

Drug is an alternative to conventional DMARDs.

  • Global Clinical Summaries from Clin Rheumatol
  • 1 comment

RA: predicting which patients will respond well to NSAID withdrawal

Some patients will succeed more than others; here’s how to tell.

  • Global Clinical Summaries from JAMA Intern Med
  • no comment

RA: do biologics and immunosuppressants increase cancer risk?

Perhaps not, with one exception.

  • Global Clinical Summaries from Rheumatology (Oxford)
  • 1 comment
  • FULLTEXT

RA: SB4 biosimilar proves safety and efficacy in head-to-head trial vs etanercept

Biosimilar drugs reduce costs and offer more treatment options.

  • Global Clinical Summaries from Rheumatology (Oxford)
  • 1 comment
  • FULLTEXT

RA: patients who respond to anti-TNF can taper dosage

But not by too much.

  • Global Clinical Summaries from Clin Rheumatol
  • 1 comment

RA: injections improve outcomes in medium-sized joints

Both drug options led to improvements, but one outperformed the other.

  • Global Clinical Summaries from Rheumatology (Oxford)
  • 1 comment
  • FULLTEXT

RA: SB5 demonstrates good results in another head-to-head trial

This time it was up against infliximab.

  • Global Clinical Summaries from Rheumatoid Arthritis
  • 1 comment

RA: adalimumab biosimilar shows comparable safety, efficacy

Data from a phase 3 randomized trial.